| 23/03/23 | 15:19:02 | 23 Mar 2023 | | Holding(s) in Company | RNS |
| 22/03/23 | 14:22:15 | 22 Mar 2023 | | Holding(s) in Company | RNS |
| 15/03/23 | 11:43:14 | 15 Mar 2023 | | AIM Rule 17 Schedule 2(g) Update | RNS |
| 03/03/23 | 16:33:11 | 3 Mar 2023 | | Publication of FY22 Annual Report | RNS |
| 23/02/23 | 10:36:48 | 23 Feb 2023 | | PDMR Dealing | RNS |
| 06/02/23 | 07:00:04 | 6 Feb 2023 | | OBD Prostate Screening EpiSwitch Blood Test Update | RNS |
| 27/01/23 | 14:36:02 | 27 Jan 2023 | | Director/PDMR Shareholding | RNS |
| 24/01/23 | 07:00:05 | 24 Jan 2023 | | Preliminary Results and Notice of AGM | RNS |
| 21/12/22 | 07:00:05 | 21 Dec 2022 | | Notice of FY22 Results and Investor Webinar | RNS |
| 19/12/22 | 07:00:08 | 19 Dec 2022 | | OBD in San Francisco for JPM Healthcare conf 2023 | RNS |
| 16/12/22 | 07:00:04 | 16 Dec 2022 | | Initial assessment of EpiSwitch assay in ALS trial | RNS |
| 14/12/22 | 12:35:36 | 14 Dec 2022 | | Holding(s) in Company | RNS |
| 14/12/22 | 07:00:04 | 14 Dec 2022 | | Exercise period extension - existing share options | RNS |
| 01/12/22 | 14:14:44 | 1 Dec 2022 | | Holding(s) in Company | RNS |
| 28/11/22 | 07:00:09 | 28 Nov 2022 | | Holding(s) in Company | RNS |
| 21/11/22 | 07:00:10 | 21 Nov 2022 | | Discussion about EpiSwitch CiRT at Key Summit | RNS |
| 18/11/22 | 16:40:57 | 18 Nov 2022 | | Second Price Monitoring Extn | RNS |
| 18/11/22 | 16:35:40 | 18 Nov 2022 | | Price Monitoring Extension | RNS |
| 14/11/22 | 11:10:34 | 14 Nov 2022 | | Director/PDMR Shareholding | RNS |
| 09/11/22 | 16:07:22 | 9 Nov 2022 | | Director/PDMR Shareholding | RNS |
| 08/11/22 | 13:57:13 | 8 Nov 2022 | | Holding(s) in Company | RNS |
| 02/11/22 | 12:37:19 | 2 Nov 2022 | | Holding(s) in Company | RNS |
| 02/11/22 | 12:35:59 | 2 Nov 2022 | | Holding(s) in Company | RNS |
| 02/11/22 | 12:33:33 | 2 Nov 2022 | | Holding(s) in Company | RNS |
| 01/11/22 | 13:20:32 | 1 Nov 2022 | | Total Voting Rights | RNS |
| 01/11/22 | 12:39:08 | 1 Nov 2022 | | Total Voting Rights | RNS |
| 01/11/22 | 10:57:46 | 1 Nov 2022 | | Holding(s) in Company | RNS |
| 31/10/22 | 11:05:54 | 31 Oct 2022 | | Holding(s) in Company | RNS |
| 31/10/22 | 11:04:25 | 31 Oct 2022 | | Holding(s) in Company | RNS |
| 31/10/22 | 11:02:49 | 31 Oct 2022 | | Holding(s) in Company | RNS |
| 31/10/22 | 10:58:39 | 31 Oct 2022 | | Holding(s) in Company | RNS |
| 31/10/22 | 10:57:52 | 31 Oct 2022 | | Holding(s) in Company | RNS |
| 31/10/22 | 10:56:39 | 31 Oct 2022 | | Holding(s) in Company | RNS |
| 28/10/22 | 14:36:52 | 28 Oct 2022 | | Holding(s) in Company | RNS |
| 27/10/22 | 12:09:01 | 27 Oct 2022 | | Result of General Meeting, Director/PDMR Dealings | RNS |
| 25/10/22 | 14:30:01 | 25 Oct 2022 | | Result of Open Offer | RNS |
| 07/10/22 | 12:00:16 | 7 Oct 2022 | | Proposed Placing and Open Offer | RNS |
| 03/10/22 | 07:00:13 | 3 Oct 2022 | | US Reimbursement Code for CiRT now available | RNS |
| 15/09/22 | 07:00:14 | 15 Sept 2022 | | ESMO data highlights unique benefit of EpiSwitch | RNS |
| 06/09/22 | 07:00:14 | 6 Sept 2022 | | CiRT highlighted at ESMO 2022 presentation | RNS |
| 05/07/22 | 07:00:07 | 5 Jul 2022 | | US reimbursement code for EpiSwitch® CiRT | RNS |
| 01/07/22 | 16:13:18 | 1 Jul 2022 | | Director/PDMR Shareholding | RNS |
| 28/06/22 | 07:00:08 | 28 Jun 2022 | | Half-year Report | RNS |
| 21/06/22 | 07:00:07 | 21 Jun 2022 | | EpiSwitch® CiRT now available in the UK | RNS |
| 17/06/22 | 07:00:04 | 17 Jun 2022 | | Notice of Interim Results Webinar | RNS |
| 15/06/22 | 07:00:04 | 15 Jun 2022 | | Notice of Results | RNS |
| 14/06/22 | 07:00:07 | 14 Jun 2022 | | OBD EpiSwitch® CiRT well received at ASCO 2022 | RNS |
| 20/05/22 | 15:50:53 | 20 May 2022 | | Director/PDMR Shareholding | RNS |
| 20/05/22 | 07:00:08 | 20 May 2022 | | PDMR Dealing / Grant of Share Options | RNS |
| 13/05/22 | 15:57:58 | 13 May 2022 | | PDMR Dealing / Grant of Share Options | RNS |
